<?xml version="1.0" encoding="UTF-8"?>
<ref id="B32-marinedrugs-17-00567">
 <label>32.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kagiampakis</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Gharibi</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Mankowski</surname>
    <given-names>M.K.</given-names>
   </name>
   <name>
    <surname>Snyder</surname>
    <given-names>B.A.</given-names>
   </name>
   <name>
    <surname>Ptak</surname>
    <given-names>R.G.</given-names>
   </name>
   <name>
    <surname>Alatas</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>LiWang</surname>
    <given-names>P.J.</given-names>
   </name>
  </person-group>
  <article-title>Potent strategy to inhibit HIV-1 by binding both gp120 and gp41</article-title>
  <source>Antimicrob. Agents Chemother.</source>
  <year>2011</year>
  <volume>55</volume>
  <fpage>264</fpage>
  <lpage>275</lpage>
  <pub-id pub-id-type="doi">10.1128/AAC.00376-10</pub-id>
  <?supplied-pmid 20956603?>
  <pub-id pub-id-type="pmid">20956603</pub-id>
 </element-citation>
</ref>
